A Non-interventional, Observational Study for Quality of Life (Overall Health Assessment) in Patients With Chronic Severe Pain During Targinact® Treatment
NCT01710917
·
clinicaltrials.gov ↗
UNKNOWN
Status
1800
Enrollment
OTHER
Sponsor class
Conditions
Chronic Severe Pain
Interventions
DRUG:
Targinact® (oxycodon/naloxon)
Sponsor
Mundipharma CVA